SavedAdd your journal

Journals / Journal of Clinical and Experimental Investigations / 2026 / Cilt: 4 Sayı: 3

A case of colistin-induced fixed drug eruption

Kolistine bağlı fiks ilaç erüpsiyonu olgusu

İsmail Necati Hakyemez
Abdulkadir Kucukbayrak
Aslihan Burcu Yikilgan
Elif Sultan Bolac
Nebil Yildiz
Cetin Boran
Hayrettin Akdeniz
Pages
374–376
Publication Date
2013-09-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

J Clin Exp Invest 2013; 4 (3): 374-376

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Several medicines, especially antimicrobials, play a role in the etiology of fixed drug eruption (FDE).
📊
Key Findings & Data:FDE which developed in an 83-year-old male patient who has been administered colistin due to Acinetobacter pneumonia is presented here since it is very rarely seen.
💡
Conclusion & Impact:J Clin Exp Invest 2013; 4 (3): 374-376
🔬Design:Makale
📍Scope:2013 Verileri
⚙️Variables:Fiks ilaç erüpsiyonu · etyoloji · kolistin

Abstract

Several medicines, especially antimicrobials, play a role in the etiology of fixed drug eruption (FDE). The clinical manifestation is quite typical for a drug-induced reaction. FDE which developed in an 83-year-old male patient who has been administered colistin due to Acinetobacter pneumonia is presented here since it is very rarely seen. Therefore colistin should also be considered in the differential diagnosis of FDE. J Clin Exp Invest 2013; 4 (3): 374-376

Özet

Fiks ilaç erüpsiyonu (FİE) etyolojisinde başta antimikrobiyaller olmak üzere çeşitli ilaçlar rol almaktadır. Klinik görünümü, ilaca bağlı gelişen bir reaksiyon için oldukça tipiktir. Literatürde, kolistine bağlı gelişen fiks ilaç erüpsiyonu olgusu bildirilmemiştir. Acinetobacter pnömonisi nedeniyle kolistin kullanılan 83 yaşındaki bir erkek hastada ortaya çıkan fiks ilaç erüpsiyonu, çok nadir görülmesi açısından sunulmuştur. FİE ayırıcı tanısında kolistinin yer alabileceği akılda tutulmalıdır.

🔖

Cite This Article

Hakyemez, İ. N., Kucukbayrak, A., Yikilgan, A. B., Bolac, E. S., Yildiz, N., Boran, C., Akdeniz, H. (2013). A case of colistin-induced fixed drug eruption. Journal of Clinical and Experimental Investigations, Cilt: 4 Sayı: 3, 374–376. https://doi.org/10.5799/ahinjs.01.2013.03.0306

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Ozkaya E. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008;6:181-188.
  2. Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430.
  3. Yahav D, Farbman L, Leibovici L, Paul M. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect 2012;18:18-29.
  4. Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol 2009;9:316-321.
  5. Bircher AJ, Scherer K. Delayed cutaneous manifes- tations of drug hypersensitivity. Med Clin North Am 2010;94:711-725.
  6. Wolff K, Johnson RA, Suurmond D. Fitzpatrick’s color atlas and synopsis of clinical dermatology. New York: McGraw Hill, 2005:556-558.
  7. Arıcan Ö, Ürün M. A case of tenoxicam induced gener- alized (multifocal) bullous fixed drug eruption. Turkish Journal of Geriatrics 2008;11:200-203.
  8. Horn TD, Hiatt KM. Cutaneous Toxicities of Drugs. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF, ed. Lever’s Histopathology of the Skin. Philadelphia, JB Lippincott Co, 2005:324-345.
  9. Habif T. Exanthems and Drug Eruptions. In: Clinical Dermatology: A Color Guide to Diagnosis and Thera- py. Philadelphia: Mosby, 2009:541-580.
  10. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006;10:27.